HomeALDX • NASDAQ
add
Aldeyra Therapeutics Inc
Previous close
$5.11
Day range
$5.24 - $6.52
Year range
$2.71 - $6.92
Market cap
360.87M USD
Avg Volume
401.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.58M | 171.87% |
Net income | -15.81M | -232.61% |
Net profit margin | — | — |
Earnings per share | -0.27 | -237.50% |
EBITDA | -16.51M | -173.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 101.15M | -29.18% |
Total assets | 104.61M | -29.48% |
Total liabilities | 33.60M | 17.77% |
Total equity | 71.00M | — |
Shares outstanding | 59.71M | — |
Price to book | 4.29 | — |
Return on assets | -37.35% | — |
Return on capital | -44.32% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.81M | -232.61% |
Cash from operations | -12.04M | -2,505.25% |
Cash from investing | -1.56M | — |
Cash from financing | 7.78K | 100.77% |
Net change in cash | -13.59M | -2,555.53% |
Free cash flow | 33.42M | 564.46% |
About
Founded
2004
Headquarters
Website
Employees
9
